 Home > Medical News > Latest Medical News > Qilu Pharmaceutical's new pancreatic cancer drug was approved for clinical use

Qilu Pharmaceutical's new pancreatic cancer drug was approved for clinical use

 Last Update: 2021-08-05
 Source: Internet
 Author: User

Tags

multivitamin drug class

public health protection

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

The Center for Drug Evaluation (CDE) of the National Food and Drug Administration of China has announced that the CEND-1 for injection introduced by Qilu Pharmaceutical has obtained an implied license for a clinical trial and is intended to be developed for the first-line treatment of advanced metastatic pancreatic cancer

Screenshot source: CDE official website

According to CDE public information, the clinical research indications approved for CEND-1 in China this time are: CEND-1 combined with gemcitabine and paclitaxel for injection (albumin-bound) for the first-line treatment of advanced metastatic pancreatic cancer

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.